777
Views
0
CrossRef citations to date
0
Altmetric
Editorial

LIF and the lung’s Stem Cell Niche: is Failure to Use LIF to Protect Against COVID-19 a Grave Omission in Managing the pandemic?

ORCID Icon
Pages 659-662 | Received 08 Oct 2020, Accepted 20 Oct 2020, Published online: 03 Nov 2020
 

Tweetable abstract

What tips the SARS/COVID-19 balance into severe pneumonia, rather than recovery? Is it insufficient LIF – the lung’s own protective growth factor at the blood–air barrier?

Author contributions

SM Metcalfe is sole author and contributor.

Financial & competing interests disclosure

The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.